DOAC Dos and Don'ts

Cardiology and hematology experts from Mayo Clinic review how and when DOACs should be deployed in patients with nonvalvular atrial fibrillation or at risk for VTE. They also address approved and pipeline reversal agents.

Source: Medscape Cardiology Podcast - May 22, 2017 Category: Cardiology Authors: Medscape Source Type: podcasts